# The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

> **NCT00162877** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (—)

## Conditions studied

- Peptic Ulcer With H. Pylori Infection
- Gastritis With H. Pylori Infection

## Interventions

- **DRUG:** Rabeprazole vs. Esomeprazole

## Key facts

- **NCT ID:** NCT00162877
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 80 (—)
- **Last updated:** 2005-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162877, "The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00162877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*